Your browser doesn't support javascript.
loading
Burden of illness in not adequately controlled chronic hypoparathyroidism: Findings from a 13-country patient and caregiver survey.
Siggelkow, Heide; Clarke, Bart L; Germak, John; Marelli, Claudio; Chen, Kristina; Dahl-Hansen, Helen; Glenister, Elizabeth; Bent-Ennakhil, Nawal; Judge, Davneet; Mycock, Katie; Bollerslev, Jens.
Affiliation
  • Siggelkow H; Clinic of Gastroenterology and Endocrinology, University of Göttingen, Göttingen, Germany.
  • Clarke BL; Mayo Clinic Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Rochester, MN, USA.
  • Germak J; Shire International GmbH, a member of the Takeda group of companies, Zug, Switzerland.
  • Marelli C; Shire International GmbH, a member of the Takeda group of companies, Zug, Switzerland.
  • Chen K; Shire Human Genetic Therapies, Inc., a member of the Takeda group of companies, Cambridge, MA, USA.
  • Dahl-Hansen H; hypoPARA NORGE, Vettre, Norway.
  • Glenister E; Hypopara UK, East Grinstead, UK.
  • Bent-Ennakhil N; Adelphi Real-World, Adelphi Mill, Bollington, UK.
  • Judge D; Adelphi Real-World, Adelphi Mill, Bollington, UK.
  • Mycock K; Adelphi Real-World, Adelphi Mill, Bollington, UK.
  • Bollerslev J; Section of Specialized Endocrinology, Oslo University Hospital, Oslo, Norway.
Clin Endocrinol (Oxf) ; 92(2): 159-168, 2020 02.
Article in En | MEDLINE | ID: mdl-31721256
ABSTRACT

OBJECTIVE:

To address knowledge gaps regarding burdens associated with not adequately controlled chronic hypoparathyroidism.

DESIGN:

Global patient and caregiver survey. STUDY POPULATIONS Patients with chronic hypoparathyroidism not adequately controlled on conventional therapy and their caregivers. MEASUREMENTS Health-related quality of life (HRQoL) and health status were evaluated using the 36-item Short Form version 2 (SF-36 v2.0) and Five-Level EuroQoL 5 Dimensions (EQ-5D-5L) instruments, respectively. Hypoparathyroidism-associated symptoms were assessed by a disease-specific Hypoparathyroidism Symptom Diary and caregiver burden via the Modified Caregiver Strain Index (MCSI).

RESULTS:

Data were obtained from 398 patients and 207 caregivers. Patients' self-rated hypoparathyroidism-related symptom severity was none (3%), mild (32%), moderate (53%) or severe (12%). Per the Hypoparathyroidism Symptom Diary, patients reported moderate, severe or very severe symptoms of physical fatigue (73%), muscle cramps (55%), heaviness in limbs (55%) and tingling (51%) over a 7-day recall period. Impacts (rated 'somewhat' or 'very much') were reported by 84% of patients for ability to exercise, 78% for sleep, 75% for ability to work and 63% for family relationships. Inverse relationships were observed between patient self-rated overall symptom severity and HRQoL and health status assessment scores-the greater the symptom severity, the lower the SF-36 and EQ-5D-5L scores. Caregiver burden increased with patient self-rated symptom severity none, 1.7 MCSI; mild, 5.4 MCSI; moderate, 9.5 MCSI; and severe, 12.5 MCSI.

CONCLUSION:

Patients with not adequately controlled hypoparathyroidism reported substantial symptoms and impacts. Greater patient symptom severity was associated with decreased patient HRQoL and health status assessments and increased caregiver burden.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quality of Life / Caregivers / Cost of Illness / Hypoparathyroidism Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Clin Endocrinol (Oxf) Year: 2020 Type: Article Affiliation country: Germany

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quality of Life / Caregivers / Cost of Illness / Hypoparathyroidism Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Clin Endocrinol (Oxf) Year: 2020 Type: Article Affiliation country: Germany